420 related articles for article (PubMed ID: 12894197)
1. Screening for content--the evolution of high throughput.
Dove A
Nat Biotechnol; 2003 Aug; 21(8):859-64. PubMed ID: 12894197
[No Abstract] [Full Text] [Related]
2. Non-optical screening platforms: the next wave in label-free screening?
Cooper MA
Drug Discov Today; 2006 Dec; 11(23-24):1068-74. PubMed ID: 17129825
[TBL] [Abstract][Full Text] [Related]
3. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule screening: it takes a village..
Gordon EJ
ACS Chem Biol; 2007 Jan; 2(1):9-16. PubMed ID: 17243777
[No Abstract] [Full Text] [Related]
5. Image-based chemical screening.
Carpenter AE
Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
[TBL] [Abstract][Full Text] [Related]
6. Optical biosensors: where next and how soon?
Cooper MA
Drug Discov Today; 2006 Dec; 11(23-24):1061-7. PubMed ID: 17129824
[TBL] [Abstract][Full Text] [Related]
7. Scaffold composition and biological relevance of screening libraries.
Shelat AA; Guy RK
Nat Chem Biol; 2007 Aug; 3(8):442-6. PubMed ID: 17637770
[TBL] [Abstract][Full Text] [Related]
8. Affinity-based screening techniques for enhancing lead discovery.
Comess KM; Schurdak ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a new drug--from target identification to ultra-high-throughput screening.
Golz S; Hüser J
Clin Lab; 2007; 53(1-2):77-9. PubMed ID: 17323829
[No Abstract] [Full Text] [Related]
10. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
Langer T; Krovat EM
Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
[TBL] [Abstract][Full Text] [Related]
11. The onset of a revolution in drug discovery.
Chatni MR
Trends Biotechnol; 2007 Apr; 25(4):142-4. PubMed ID: 17306391
[TBL] [Abstract][Full Text] [Related]
12. Label-free cell-based assays with optical biosensors in drug discovery.
Fang Y
Assay Drug Dev Technol; 2006 Oct; 4(5):583-95. PubMed ID: 17115929
[TBL] [Abstract][Full Text] [Related]
13. A review of high throughput technology for the screening of natural products.
Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
[TBL] [Abstract][Full Text] [Related]
14. [From systematic analysis of protein interaction networks to chemical-biology].
Natsume T
Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1649-54. PubMed ID: 18051394
[No Abstract] [Full Text] [Related]
15. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
Schirlin D; Galvan M; Le Fur G
Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
[TBL] [Abstract][Full Text] [Related]
16. Application of statistical 'design of experiments' methods in drug discovery.
Tye H
Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624
[TBL] [Abstract][Full Text] [Related]
17. Automated medicinal chemistry.
Koppitz M; Eis K
Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909
[TBL] [Abstract][Full Text] [Related]
18. Fragment-based drug design: combining philosophy with technology.
Bartoli S; Fincham CI; Fattori D
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):422-9. PubMed ID: 17659483
[TBL] [Abstract][Full Text] [Related]
19. Screening for drug discovery: the leading question.
Smith A
Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
[No Abstract] [Full Text] [Related]
20. US NHGRI launches chemical attack on drug development gap.
Garber K
Nat Biotechnol; 2003 Nov; 21(11):1253-4. PubMed ID: 14595338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
